Where Global Innovation
and Capital Meet
Sectors ConsumerUniversityEnergyFinancialHealthcareIndustrialITMediaServicesTelecomsTransportThe Art of CVCStartups

Page 94

Open opts for $100m series C round

Google was among the investors that helped the digital banking platform close its latest round at a $500m valuation, taking its overall funding to $137m.

Oct 13, 2021

Daily Deal Round Up: October 12, 2021

Mobiliar took part in a $35m round for medicine transportation system developer SkyCell while Nice Investment co-led wealth management software provider Fount's $33.4m series C.

Oct 12, 2021

Magic Leap pockets $500m in funding

The augmented reality technology developer, which counts a host of corporates among its investors, attracted new funding at a $2bn post-money valuation.

Oct 12, 2021

XinChao chases down $400m from corporates

JD.com has led the elevator advertising technology provider’s latest round, investing together with fellow returning backer Baidu.

Oct 12, 2021

Wiz secures $250m in series C funding

Existing investor Salesforce participated in a round for Wiz that valued the the cybersecurity software developer at $6bn.

Oct 12, 2021

LandTech constructs series A round

JLL came back to reinvest in the land development software developer through a $57.2m round which will fund international expansion.

Oct 12, 2021

Brave Care brightens up with $25m

Mednax led the paediatric healthcare provider's series B round, pushing its overall funding past the $40m mark.

Oct 12, 2021

Cornami finds SoftBank for $50m series C

SoftBank led the computing performance platform developer's series C round, which will support the growth of its outbound partner programme work.

Oct 12, 2021

Daily Deal Round Up: October 11, 2021

Corporate-backed cloud networking software provider Pluribus pushed its total funding to at least $110m while IAG has exited Hyper Anna in an acquisition by Alteryx.

Oct 11, 2021

Neumora secures $500m in funding

Amgen, SoftBank and Alexandria Real Estate Equities helped the neurodegenerative disease drug developer publicly launch with $500m in funding.

Oct 11, 2021
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here